327 results on '"Hurley, Leo"'
Search Results
2. Beyond the HIV Care Continuum and Viral Suppression: Broadening the Scope of Quality Metrics for Total HIV Patient Care.
3. Cardiovascular Risk Estimation Is Suboptimal in People With HIV.
4. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017
5. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study
6. HIV Pre-exposure Prophylaxis Continuum of Care Among Transgender Individuals in an Integrated Health care System
7. Improved Gonorrhea and Chlamydia Testing Among Men Who Have Sex With Men Living With HIV Through Implementation of Self-Collected Tests
8. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population
9. Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures
10. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients
11. Low-Intensity Outreach to Increase Uptake of HIV Preexposure Prophylaxis Among Patients with Sexually Transmitted Infections
12. Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1–Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing
13. Improvement of Sexually Transmitted Disease Screening Among HIV-Infected Men Who Have Sex With Men Through Implementation of a Standardized Sexual Risk Assessment Tool
14. Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting
15. Declining Relative Risk for Myocardial Infarction Among HIV-Positive Compared With HIV-Negative Individuals With Access to Care
16. Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms
17. Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals
18. Perceptions of Human Immunodeficiency Virus Testing Services Among HIV-Positive Persons Not in Medical Care
19. HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance
20. The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System
21. Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System
22. Home Blood Pressure Monitoring: Effect on Use of Medical Services and Medical Care Costs
23. Home Blood Pressure Monitoring for Mild Hypertensives
24. HIV infection and incidence of ischemic stroke
25. Using a report card to increase HIV screening in a large primary care group practice
26. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens
27. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy
28. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/ml
29. Missed Office Visits and Risk of Mortality Among HIV-Infected Subjects in a Large Healthcare System in the United States
30. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection
31. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
32. Evaluation of a non-name-based HIV reporting system in San Francisco
33. Short-Term Clinical Outcomes Among Treatment-Experienced HIV-Positive Patients with Early Low Level Viremia
34. HIV Quality Performance Measures in a Large Integrated Health Care System
35. Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
36. Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007–2017
37. Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States
38. Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
39. Efficacy and Safety of Ritonavir-Boosted and Unboosted Atazanavir Among Antiretroviral-Naïve Patients
40. Incidence of pancreatitis in HIV-infected patients: comment on findings in EuroSIDA cohort
41. Surgical Outcomes in Human Immunodeficiency Virus–Infected Patients in the Era of Highly Active Antiretroviral Therapy
42. Smoking and cryptococcosis in AIDS patients
43. Cryptococcosis: the 1981–2000 epidemic
44. Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy
45. Cardiovascular Disease and HIV Infection
46. A Randomized Controlled Trial of Test-and-Treat Strategy for Helicobacter pylori: Clinical Outcomes and Health Care Costs in a Managed Care Population Receiving Long-term Acid Suppression Therapy for Physician-Diagnosed Peptic Ulcer Disease
47. Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone disease
48. Does Use of Potent Antiretroviral Therapy Differ by Health Care Setting?
49. Identifying Women With Cervical Neoplasia: Using Human Papillomavirus DNA Testing for Equivocal Papanicolaou Results
50. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.